ADGRG6
Adhesion G-protein coupled receptor G6
Also known as: AGRG6_HUMAN, FLJ14937, GPR126
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86SQ4
- Gene
- ADGRG6
- Ensembl
- ENSG00000112414
- Chromosome
- 6
- Canonical length
- 1221 aa
- Protein class
- Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
This gene, which is upregulated in human umbilical vein endothelial cells, encodes a G protein-coupled receptor. Variations in this gene can affect a person's stature. Multiple transcript variants encoding different proteins have been found for this gene. [provided by RefSeq, Mar 2009]
Canonical amino-acid sequenceUniProt
1221 residues, UniProt reviewed canonical sequence.
>Q86SQ4|ADGRG6
1 MMFRSDRMWS CHWKWKPSPL LFLFALYIMC VPHSVWGCAN CRVVLSNPSG TFTSPCYPND
61 YPNSQACMWT LRAPTGYIIQ ITFNDFDIEE APNCIYDSLS LDNGESQTKF CGATAKGLSF
121 NSSANEMHVS FSSDFSIQKK GFNASYIRVA VSLRNQKVIL PQTSDAYQVS VAKSISIPEL
181 SAFTLCFEAT KVGHEDSDWT AFSYSNASFT QLLSFGKAKS GYFLSISDSK CLLNNALPVK
241 EKEDIFAESF EQLCLVWNNS LGSIGVNFKR NYETVPCDST ISKVIPGNGK LLLGSNQNEI
301 VSLKGDIYNF RLWNFTMNAK ILSNLSCNVK GNVVDWQNDF WNIPNLALKA ESNLSCGSYL
361 IPLPAAELAS CADLGTLCQA TVNSPSTTPP TVTTNMPVTN RIDKQRNDGI IYRISVVIQN
421 ILRHPEVKVQ SKVAEWLNST FQNWNYTVYV VNISFHLSAG EDKIKVKRSL EDEPRLVLWA
481 LLVYNATNNT NLEGKIIQQK LLKNNESLDE GLRLHTVNVR QLGHCLAMEE PKGYYWPSIQ
541 PSEYVLPCPD KPGFSASRIC FYNATNPLVT YWGPVDISNC LKEANEVANQ ILNLTADGQN
601 LTSANITNIV EQVKRIVNKE ENIDITLGST LMNIFSNILS SSDSDLLESS SEALKTIDEL
661 AFKIDLNSTS HVNITTRNLA LSVSSLLPGT NAISNFSIGL PSNNESYFQM DFESGQVDPL
721 ASVILPPNLL ENLSPEDSVL VRRAQFTFFN KTGLFQDVGP QRKTLVSYVM ACSIGNITIQ
781 NLKDPVQIKI KHTRTQEVHH PICAFWDLNK NKSFGGWNTS GCVAHRDSDA SETVCLCNHF
841 THFGVLMDLP RSASQLDARN TKVLTFISYI GCGISAIFSA ATLLTYVAFE KLRRDYPSKI
901 LMNLSTALLF LNLLFLLDGW ITSFNVDGLC IAVAVLLHFF LLATFTWMGL EAIHMYIALV
961 KVFNTYIRRY ILKFCIIGWG LPALVVSVVL ASRNNNEVYG KESYGKEKGD EFCWIQDPVI
1021 FYVTCAGYFG VMFFLNIAMF IVVMVQICGR NGKRSNRTLR EEVLRNLRSV VSLTFLLGMT
1081 WGFAFFAWGP LNIPFMYLFS IFNSLQGLFI FIFHCAMKEN VQKQWRQHLC CGRFRLADNS
1141 DWSKTATNII KKSSDNLGKS LSSSSIGSNS TYLTSKSKSS STTYFKRNSH TDNVSYEHSF
1201 NKSGSLRQCF HGQVLVKTGP CLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADGRG6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 67 nTPM
Expression across tissuesHPA
Tissue
- liver: 67 nTPM
- placenta: 45 nTPM
- duodenum: 17 nTPM
- lung: 14 nTPM
- urinary bladder: 14 nTPM
- skin: 14 nTPM
Single-cell type
- tuft cells: 300 nCPM
- hepatocytes: 292 nCPM
- hematopoietic stem cells: 229 nCPM
- papillary tip epithelial cells: 224 nCPM
- urothelial cells: 193 nCPM
- mesothelial cells: 145 nCPM
Immune cell
- myeloid DC: 0.8 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- thalamus: 9.7 nTPM
- midbrain: 6.3 nTPM
- amygdala: 5.5 nTPM
- spinal cord: 5.5 nTPM
- medulla oblongata: 5 nTPM
- pons: 4.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ADGRG6.
Disease | AllUniProt
Conditions ADGRG6 is implicated in, by any mechanism.
- Lethal congenital contracture syndrome 9 (LCCS9) MIM:616503
Disease | GeneticClinVar
9 pathogenic / likely-pathogenic of 268 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Lethal congenital contracture syndrome 9
- Arthrogryposis multiplex congenita
Disease | ImmuneIEDB
Conditions an epitope on ADGRG6 was assayed in.
- narcolepsy B cell
- multiple sclerosis B cell
- peripheral nervous system disease B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.47
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.23
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
- adenylate cyclase-modulating G protein-coupled receptor signaling pathway
- cartilage development
- cell surface receptor signaling pathway
- establishment of blood-brain barrier
- G protein-coupled receptor signaling pathway
- heart trabecula formation
- myelination
- myelination in peripheral nervous system
- nervous system development
- placenta development
- regulation of bone mineralization
- regulation of sprouting angiogenesis
- Schwann cell differentiation
Molecular functions
- collagen binding
- endopeptidase activity
- extracellular matrix binding
- G protein-coupled receptor activity
- laminin binding
- metal ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GPS motif
- GPCR, family 2, secretin-like
- CUB domain
- Pentraxin domain
- Concanavalin A-like lectin/glucanase domain superfamily
- GPCR, family 2-like, 7TM
- GPCR, family 2, secretin-like, conserved site
- Spermadhesin, CUB domain superfamily
- GAIN domain superfamily
- GAIN, subdomain B
- Adhesion G-protein coupled receptor G2/6, GAIN domain
- 7 transmembrane receptor (Secretin family)
- Pentaxin family
- CUB domain
- GPCR proteolysis site, GPS, motif
- ADGRG2-like, GAIN domain
- Adhesion GPCR Gpr126, SEA domain
- SEA domain of adhesion GPCR Gpr126
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADGRG6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADGRG6 as an antibody target. Whether an autoantibody or antibody against ADGRG6 could matter depends on whether native ADGRG6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADGRG6 is annotated at the cell surface, where native ADGRG6 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ADGRG6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...